The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Enlivex Therapeutics Ltd(NASDAQ:ENLV) 
Enlivex Therapeutics Ltd. operates as a clinical stage macrophage reprogramming immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immu...
Share this website to your friends
Enlivex Therapeutics Days Payable Outstanding ttm (DPO)
Enlivex Therapeutics Days Inventory Outstanding ttm (DIO)
Enlivex Therapeutics Op Cashflow Per Share ttm
Enlivex Therapeutics Free Cashflow Per Share ttm
Enlivex Therapeutics Cash Per Share ttm
Enlivex Therapeutics (GAAP) P/E ratio ttm
Enlivex Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.